[
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company’s (BMY) Dividend Track Record: A Must-Have for a Dividend Stock Portfolio",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the Best Stocks for a Dividend Stock Portfolio. Bristol-Myers Squibb Company (NYSE:BMY) is a pharmaceutical company focused on developing treatments across cancer, blood disorders, cardiovascular disease, immunology, and neuroscience. Its portfolio includes widely recognized therapies such as Opdivo for oncology and Eliquis for preventing blood clots, alongside a […]",
    "url": "https://finnhub.io/api/news?id=8d22bf143e04b7f82e1a795c66a3785c47a89907074a2ee53279669e98c7855e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758325532,
      "headline": "Bristol-Myers Squibb Company’s (BMY) Dividend Track Record: A Must-Have for a Dividend Stock Portfolio",
      "id": 136823608,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the Best Stocks for a Dividend Stock Portfolio. Bristol-Myers Squibb Company (NYSE:BMY) is a pharmaceutical company focused on developing treatments across cancer, blood disorders, cardiovascular disease, immunology, and neuroscience. Its portfolio includes widely recognized therapies such as Opdivo for oncology and Eliquis for preventing blood clots, alongside a […]",
      "url": "https://finnhub.io/api/news?id=8d22bf143e04b7f82e1a795c66a3785c47a89907074a2ee53279669e98c7855e"
    }
  },
  {
    "ts": null,
    "headline": "US Weighs Trump-Branded Website to Help Shop for Cheaper Drugs",
    "summary": "The initiative is part of Trump’s demands that drugmakers reduce their prices to align them with what other developed countries pay, according to the people, who spoke on condition of anonymity to discuss plans that are not yet public.  The proposed website would allow patients to search for specific medicines and be connected with platforms that sell them, the people said.",
    "url": "https://finnhub.io/api/news?id=0e750c560c0ea09bf3dc6730b90444afd04249631e5b78e5380f5bdb5e0db388",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758314575,
      "headline": "US Weighs Trump-Branded Website to Help Shop for Cheaper Drugs",
      "id": 136823430,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The initiative is part of Trump’s demands that drugmakers reduce their prices to align them with what other developed countries pay, according to the people, who spoke on condition of anonymity to discuss plans that are not yet public.  The proposed website would allow patients to search for specific medicines and be connected with platforms that sell them, the people said.",
      "url": "https://finnhub.io/api/news?id=0e750c560c0ea09bf3dc6730b90444afd04249631e5b78e5380f5bdb5e0db388"
    }
  },
  {
    "ts": null,
    "headline": "Can Bristol Myers Squibb's Restructuring Program Boost Earnings Growth?",
    "summary": "Bristol Myers ramps up a $2.5B restructuring plan to cut costs, streamline operations, and offset pressure from generic competition.",
    "url": "https://finnhub.io/api/news?id=bec503802a9be9cc127ad63c000bb5149415c0790f3e31905a8782af433cdc78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758294840,
      "headline": "Can Bristol Myers Squibb's Restructuring Program Boost Earnings Growth?",
      "id": 136820024,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers ramps up a $2.5B restructuring plan to cut costs, streamline operations, and offset pressure from generic competition.",
      "url": "https://finnhub.io/api/news?id=bec503802a9be9cc127ad63c000bb5149415c0790f3e31905a8782af433cdc78"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025",
    "summary": "PRINCETON, N.J., September 19, 2025--Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025",
    "url": "https://finnhub.io/api/news?id=6639f6fc1a8f9200a98380b47292e8ee6d3904aadd2d3cffe577f6bc65a3cfa1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758283140,
      "headline": "Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025",
      "id": 136818484,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., September 19, 2025--Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025",
      "url": "https://finnhub.io/api/news?id=6639f6fc1a8f9200a98380b47292e8ee6d3904aadd2d3cffe577f6bc65a3cfa1"
    }
  }
]